These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 29877292)

  • 1. Development of an FVIII Inhibitor in a Mild Hemophilia Patient with a Phe595Cys Mutation.
    Yamanouchi J; Tokumoto D; Ikeda Y; Maruta M; Kaneko M; Hato T; Yasukawa M
    Intern Med; 2018 Nov; 57(21):3179-3182. PubMed ID: 29877292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mild hemophilia A patient with novel Pro1809Leu mutation develops an anti-C2 antibody inhibiting allogeneic but not autologous factor VIII activity.
    Yada K; Nogami K; Takeyama M; Ogiwara K; Wakabayashi H; Shima M
    J Thromb Haemost; 2015 Oct; 13(10):1843-53. PubMed ID: 26278069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factor VIII inhibitor development in Egyptian hemophilia patients: does intron 22 inversion mutation play a role?
    Sherief LM; Gaber OA; Youssef HM; Sherbiny HS; Mokhtar WA; Ali AAA; Kamal NM; Abdel Maksoud YH
    Ital J Pediatr; 2020 Sep; 46(1):129. PubMed ID: 32928254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variation in baseline factor VIII concentration in a retrospective cohort of mild/moderate hemophilia A patients carrying identical F8 mutations.
    Loomans JI; van Velzen AS; Eckhardt CL; Peters M; Mäkipernaa A; Holmstrom M; Brons PP; Dors N; Haya S; Voorberg J; van der Bom JG; Fijnvandraat K
    J Thromb Haemost; 2017 Feb; 15(2):246-254. PubMed ID: 27943580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factor VIII (FVIII) gene mutations in 120 patients with hemophilia A: detection of 26 novel mutations and correlation with FVIII inhibitor development.
    Repessé Y; Slaoui M; Ferrandiz D; Gautier P; Costa C; Costa JM; Lavergne JM; Borel-Derlon A
    J Thromb Haemost; 2007 Jul; 5(7):1469-76. PubMed ID: 17445092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Screening and analysis of coagulation factor VIII inhibitor in patients with hemophilia A].
    Zhang AL; Yang LH; Liu XE; Zhao H; Zhang JH; Dong CX; Qi XL; Qin XY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Aug; 19(4):968-70. PubMed ID: 21867625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In silico calculated affinity of FVIII-derived peptides for HLA class II alleles predicts inhibitor development in haemophilia A patients with missense mutations in the F8 gene.
    Pashov AD; Calvez T; Gilardin L; Maillère B; Repessé Y; Oldenburg J; Pavlova A; Kaveri SV; Lacroix-Desmazes S
    Haemophilia; 2014 Mar; 20(2):176-84. PubMed ID: 24118514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Molecular analysis of a patient with hemophilia A caused by FVIII His99Arg mutation].
    Qin HH; Wang XF; Ding QL; Lu YL; Dai J; Xi XD; Wang HL
    Zhonghua Xue Ye Xue Za Zhi; 2011 Sep; 32(9):587-91. PubMed ID: 22338150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4+ T-cell clones specific for wild-type factor VIII: a molecular mechanism responsible for a higher incidence of inhibitor formation in mild/moderate hemophilia A.
    Jacquemin M; Vantomme V; Buhot C; Lavend'homme R; Burny W; Demotte N; Chaux P; Peerlinck K; Vermylen J; Maillere B; van der Bruggen P; Saint-Remy JM
    Blood; 2003 Feb; 101(4):1351-8. PubMed ID: 12393451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Molecular genetics of hemophilia A].
    De Brasi CD; Slavutsky IR; Larripa IB
    Medicina (B Aires); 1996; 56(5 Pt 1):509-17. PubMed ID: 9239887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The molecular basis for cross-reacting material-positive hemophilia A due to missense mutations within the A2-domain of factor VIII.
    Amano K; Sarkar R; Pemberton S; Kemball-Cook G; Kazazian HH; Kaufman RJ
    Blood; 1998 Jan; 91(2):538-48. PubMed ID: 9427707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factor VIII Ise (R2159C) in a patient with mild hemophilia A, an abnormal factor VIII with retention of function but modification of C2 epitopes.
    Suzuki H; Shima M; Arai M; Kagawa K; Fukutake K; Kamisue S; Nakai H; Morichika S; Tanaka I; Inoue M; Gale K; Tuddenham EG; Yoshioka A
    Thromb Haemost; 1997 May; 77(5):862-7. PubMed ID: 9184393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-reacting Material-positive Hemophilia A Diagnosed in a Patient with a Spontaneous Thigh Hemorrhage.
    Saito T; Mukae J; Nakamura Y; Inaba H; Nogami K; Koyama T; Fukutake K; Yamamoto K
    Intern Med; 2017; 56(13):1719-1723. PubMed ID: 28674365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The molecular basis of hemophilia A: genotype-phenotype relationships and inhibitor development.
    Goodeve AC; Peake IR
    Semin Thromb Hemost; 2003 Feb; 29(1):23-30. PubMed ID: 12640561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune response to FVIII in hemophilia A: an overview of risk factors.
    Ghosh K; Shetty S
    Clin Rev Allergy Immunol; 2009 Oct; 37(2):58-66. PubMed ID: 19148784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Female hemophilia A heterozygous for a de novo frameshift and a novel missense mutation of factor VIII.
    Cai XH; Wang XF; Dai J; Fang Y; Ding QL; Xie F; Wang HL
    J Thromb Haemost; 2006 Sep; 4(9):1969-74. PubMed ID: 16805874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-DRB1-factor VIII binding is a risk factor for inhibitor development in nonsevere hemophilia: a case-control study.
    Kempton CL; Payne AB
    Blood Adv; 2018 Jul; 2(14):1750-1755. PubMed ID: 30037801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tyr2105Cys mutation in exon 22 of FVIII gene is a risk factor for the development of inhibitors in patients with mild/moderate haemophilia A.
    Franchini M; Girelli D; Olivieri O; Castaman G; Lippi G; Poli G; Salvagno GL; Tagariello G; Giuffrida A; de Gironcoli M; Morfini M; Berntorp E; Gandini G
    Haemophilia; 2006 Jul; 12(4):448-51. PubMed ID: 16834751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of inhibitors in mild/moderate haemophilia A.
    Peerlinck K; Jacquemin M
    Haemophilia; 2006 Dec; 12 Suppl 6():43-7. PubMed ID: 17123393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of factor VIII gene mutations in 101 patients with haemophilia A: mutation analysis by inversion screening and multiplex PCR and CSGE and molecular modelling of 10 novel missense substitutions.
    Jayandharan G; Shaji RV; Baidya S; Nair SC; Chandy M; Srivastava A
    Haemophilia; 2005 Sep; 11(5):481-91. PubMed ID: 16128892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.